A detailed history of Mork Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mork Capital Management, LLC holds 30,000 shares of BMY stock, worth $1.73 Million. This represents 1.13% of its overall portfolio holdings.

Number of Shares
30,000
Previous 30,000 -0.0%
Holding current value
$1.73 Million
Previous $1.25 Million 24.66%
% of portfolio
1.13%
Previous 0.99%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 18, 2020

BUY
$54.82 - $64.09 $1.55 Million - $1.81 Million
28,236 Added 1600.68%
30,000 $1.76 Million
Q2 2020

Aug 13, 2020

SELL
$54.82 - $64.09 $1.55 Million - $1.81 Million
-28,236 Reduced 94.12%
1,764 $1.76 Million
Q1 2019

May 13, 2019

BUY
$45.12 - $53.8 $1.35 Million - $1.61 Million
30,000 New
30,000 $1.43 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mork Capital Management, LLC Portfolio

Follow Mork Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mork Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mork Capital Management, LLC with notifications on news.